Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...
A viral clip from a BBC documentary shows that an HIV protein was used in a Covid vaccine trial, but fails to mention the ...
Veteran vaccine researcher Arturo Casadevall gives a podcast primer on vaccinations, from how they work on a molecular level to common misconceptions ...
Opinion
Hosted on MSN1dOpinion
Plug health funding gap
The alarm over the apparent failure by the National Treasury to allocate some Sh68 billion for the procurement of essential medical equipment and supplies is understandable and calls for urgent ...
Texas health officials said Tuesday the state now has 58 confirmed measles cases. What is measles, how do you contract it and ...
South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded ...
South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded ...
Scientists believe they are on the cusp of a vaccine for HIV. Two promising vaccines were set to go to additional trials. But the vials of vaccines are in the freezer due to financial cuts by the ...
A summary of current health news highlights a bird flu outbreak in Canada, halted HIV vaccine trials in South Africa, a legal ...
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
The development of a promising HIV vaccine led by South African researchers has been halted due to funding cuts from USAID, following U.S. President Donald Trump's policy changes. The vaccine program, ...
GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...